Article
Utilization of the cellular stress response to sensitize cancer cells to TRAIL-mediated apoptosis
5 Jul 2012
Abstract excerpt
INTRODUCTION: Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) is a promising death ligand who has received significant attention due to its specific anti-cancer activity. Recently, a number of clinical trials involving either recombinant soluble TRAIL or agonistic death receptor (DR) antibodies have even been initiated. One major caveat in TRAIL-based anti-cancer therapies is that a considerable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
